Pfizer's Zoetis wins strong response for US$3.65bn debut bond sale

17 January 2013 | By Andrea Johnson, Anthony Hughes

Pfizer unit Zoetis on Wednesday drew strong demand for its debut bond offering, a US$3.65bn four-part deal that attracted an order book of about US$30bn and allowed it to sharply tighten pricing from original guidance, according to market sources.

Please login